These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 15099785)
1. Depo medroxyprogesterone acetate (DMPA) therapy for uterine myomata prior to surgery. Johnson N; Fletcher H; Reid M Int J Gynaecol Obstet; 2004 May; 85(2):174-6. PubMed ID: 15099785 [No Abstract] [Full Text] [Related]
2. Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study. Venkatachalam S; Bagratee JS; Moodley J J Obstet Gynaecol; 2004 Oct; 24(7):798-800. PubMed ID: 15763792 [TBL] [Abstract][Full Text] [Related]
3. Corona stenting in a patient menorrhagia: use of a gonadotrophin releasing hormone agonist to facilitate anticoagulation. Khurana C; Taylor P; de Belder MA Int J Cardiol; 1998 Jan; 63(1):89-91. PubMed ID: 9482151 [TBL] [Abstract][Full Text] [Related]
4. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial. Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549 [TBL] [Abstract][Full Text] [Related]
5. Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate. Meirow D; Rabinovici J; Katz D; Or R; Shufaro Y; Ben-Yehuda D Cancer; 2006 Oct; 107(7):1634-41. PubMed ID: 16944540 [TBL] [Abstract][Full Text] [Related]
6. Ulipristal acetate versus placebo for fibroid treatment before surgery. Donnez J; Tatarchuk TF; Bouchard P; Puscasiu L; Zakharenko NF; Ivanova T; Ugocsai G; Mara M; Jilla MP; Bestel E; Terrill P; Osterloh I; Loumaye E; N Engl J Med; 2012 Feb; 366(5):409-20. PubMed ID: 22296075 [TBL] [Abstract][Full Text] [Related]
8. [Myomectomy performed after Zoladex preparation with subsequent repair of the uterine wall via a balloon catheter in the uterine cavity]. Nikolov A; Raĭcheva R; Maĭnkhard K Akush Ginekol (Sofiia); 1998; 37(1):55-7. PubMed ID: 9770805 [No Abstract] [Full Text] [Related]
9. Levonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumes. Murat Naki M; Tekcan C; Ozcan N; Cebi M Fertil Steril; 2010 Jun; 94(1):371-4. PubMed ID: 19896649 [TBL] [Abstract][Full Text] [Related]
10. [Medical treatment of the uterine miomas in perimenopausal patients]. Olvera-Maldonado AJ; Martínez-Uribe A; Rendón-Macías ME; Sangines-Martínez A Ginecol Obstet Mex; 2015 Jan; 83(1):41-7. PubMed ID: 26016315 [TBL] [Abstract][Full Text] [Related]